Stocksigma LogoStocksigma Logo

Shukra Medtech Schedules Board Meeting to Approve Q2 Results

Shukra Medtech Limited (formerly Shukra Pharmaceuticals Limited) has scheduled a Board of Directors meeting on 3rd Nov'26 at its registered office

Shukra Medtech Schedules Board Meeting to Approve Q2 Results

Shukra Pharmaceuticals Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Shukra Medtech Schedules Board Meeting to Approve Q2 Results Shukra Medtech Limited (formerly Shukra Pharmaceuticals Limited) has scheduled a Board of Directors meeting on 3rd Nov'26 at its registered office. The board will inter alia consider and approve the company's unaudited financial results for the second quarter and half-year ended 30th Sep'26, alongside the Auditor's Limited Review Report.

Original exchange filing (PDF)

More announcements from Shukra Pharmaceuticals Ltd

All Shukra Pharmaceuticals Ltd announcements